Canadian Medical Association Journal · 2004 · 80 citations · 0 references
MedicinePharmacologyPharmacotherapyAdolescent MedicinePediatric PharmacotherapyPsychopharmacologyAdolescent PharmacotherapyPediatric Clinical TrialsPediatric PharmacologyPediatric PsychopharmacologyPsychopharmacology In AdolescentsPsychopharmacology In ChildrenAntidepressant EfficacyAntidepressant SafetyAntidepressant Use In YouthPediatric Antidepressant TherapyPediatric Antidepressant TreatmentPediatric Antidepressant UsePediatric Depression PharmacotherapyTricyclic Antidepressants In Children
An internal document advised staff at the international drug giant GlaxoSmithKline (GSK) to withhold clinical trial findings in 1998 that indicated the antidepressant paroxetine (Paxil in North America and Seroxat in the UK) had no beneficial effect in treating adolescents. ![Figure][1]</img>